Inventor · disambiguated record
Teru Hideshima
Also filed as: HIDESHIMA TERU
14 granted patents·6 pending applications·44 citations·filing 2005–2022
89Inventor score
Files withDANA FARBER CANCER INST INC7ACETYLON PHARMACEUTICALS INC5ANDERSON KENNETH C3HARVARD COLLEGE2DAELKEN BENJAMIN1
Top patents by PatentIndex Score
20 records- 0193US9988343B2Inhibitors of histone deacetylaseDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 5, 2018·7 cites·22 claims
- 0290US8999289B2Treatment of protein degradation disordersANDERSON KENNETH C·Filed 2006·Granted Apr 7, 2015·16 cites·32 claims
- 0387US9572854B2Treatment of protein degradation disordersHARVARD COLLEGE·Filed 2015·Granted Feb 21, 2017·6 cites·20 claims
- 0485US11337975B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted May 24, 2022·2 cites·5 claims
- 0583US10172905B1Treatment of protein degradation disordersHARVARD COLLEGE·Filed 2017·Granted Jan 8, 2019·3 cites·20 claims
- 0681US9446146B2Methods and agents for improving targeting of CD138 expressing tumor cellsDAELKEN BENJAMIN·Filed 2008·Granted Sep 20, 2016·10 cites·10 claims
- 0773US12053468B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·0 cites·14 claims
- 0869US2023190744A1Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (pd-l1) inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0966US2020323849A1Combinations of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1063US11497746B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Nov 15, 2022·0 cites·3 claims
- 1163USRE49240EInhibitors of histone deacetylaseMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Oct 11, 2022·0 cites·22 claims
- 1257US2015105358A1Combinations of histone deacetylase inhibitors and immunomodulatory drugsQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 1353US8026230B2Methods and compositions for treating cancer using proteasome inhibitorsDANA FARBER CANCER INST INC·Filed 2005·Granted Sep 27, 2011·0 cites·18 claims
- 1453US2024216354A1Immunomodulatory imide drugs as zeta-chain-associated protein kinase 70 (zap70) agonists and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1551US2006166947A1Multiple myeloma treatmentsANDERSON KENNETH C·Filed 2005·Application pending·0 cites
- 1650US8685954B2Methods and compositions for treating cancer using proteasome inhibitorsANDERSON KENNETH C·Filed 2011·Granted Apr 1, 2014·0 cites·20 claims
- 1750US2024124459A9Prpk inhibitorsDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1847US10302644B2Compositions and methods for treating multiple myelomaDANA FARBER CANCER INST INC·Filed 2015·Granted May 28, 2019·0 cites·6 claims
- 1943US11447467B2Compounds for the degradation of STK4 and treatment of hematologic malignanciesDANA FARBER CANCER INST INC·Filed 2018·Granted Sep 20, 2022·0 cites·20 claims
- 2042US9969679B2Anti-proliferative compounds and uses thereofDANA FARBER CANCER INST INC·Filed 2013·Granted May 15, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Teru Hideshima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →